Scott Platshon Overview

  • Primary Position
  • Chief Operating...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size
  • 000.0

  • Med. Valuation
  • 000.0

Scott Platshon General Information

Biography

Mr. Scott Platshon serves as Chief Operating Officer at Nuvation Bio. He serves as Board Member at Ajax Therapeutics and Kumquat Biosciences. He serves as a Partner at EcoR1 Capital. He holds a bioengineering from Stanford University.

Contact Information

Primary Position
Chief Operating Officer, Panacea Acquisition
Education
Stanford University, BS (Bachelor of Science)
Gender
Male
Phone
+1 (650) 000-0000
Address
  • 357 Tehama Street
  • Floor 3
  • San Francisco, CA 94103
  • United States

Scott Platshon Positions (1)

Firm name Firm type Title Location Industry Since
EcoR1 Capital Investor Partner San Francisco, CA Venture Capital 0000-00-00

Scott Platshon Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Ajax Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed New York, NY 0000-00-0
Kumquat Biosciences Drug Discovery Privately Held (backing) Venture Capital-Backed San Diego, CA 0000-00-0
Zymeworks Biotechnology Publicly Held Formerly VC-backed Vancouver, Canada 0000-00-0

Scott Platshon Lead Partner on Deals (4)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Ajax Therapeutics 13-May-2024 Later Stage VC (Series C) 0000 Completed Drug Discovery New York, NY
Terremoto Biosciences 02-Nov-2023 00000 00000 00 00000 Completed Drug Delivery San Francisco, CA
Ajax Therapeutics 01-Jun-2021 Early Stage VC (Series B) 0000 Completed Drug Discovery New York, NY
Kumquat Biosciences 08-Sep-2019 Early Stage VC (Series A) 000.00 Completed Drug Discovery San Diego, CA

Scott Platshon Network (53)

Board Members (40)

Name Company Representing Location From
Donald Drakeman Ph.D Zymeworks Self Vancouver, Canada 0000-00-00
Ross Levine MD Ajax Therapeutics Ajax Therapeutics New York, NY 0000-00-00
00000000 00 Zymeworks Self Vancouver, Canada 0000-00-00
0000 000000 Zymeworks Self Vancouver, Canada
00000000 00 Kumquat Biosciences Roche Venture Fund San Diego, CA

Portfolio Executives (11)

Name Company Role Deal date Location
David Steensma Ajax Therapeutics Chief Medical Officer 13-May-2024 New York, NY
Olli Silvennoinen Ajax Therapeutics Co-Founder 13-May-2024 New York, NY
0000 0000 Ajax Therapeutics Co-Founder & Chairman of Scientific Advisory Board 13-May-2024 New York, NY
000000 00 Ajax Therapeutics Co-Founder, Chief Executive Officer & Board Member 13-May-2024 New York, NY
000000 00 Terremoto Biosciences Senior Director of Finance and Accounting 02-Nov-2023 San Francisco, CA

Fund Team Members (2)

Name Investor Fund Fund Location
0000 0000000 EcoR1 Capital 00000 000000 San Francisco, CA
00000000 000 EcoR1 Capital 00000 000000 San Francisco, CA

Scott Platshon Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
EcoR1 Venture Opportunity Fund EcoR1 Capital Venture - General Closed 2020 000.0 000000 000000

Scott Platshon FAQs

  • Who is Scott Platshon?

    Mr. Scott Platshon serves as Chief Operating Officer at Nuvation Bio.

  • How much does Scott Platshon typically invest?

    Scott Platshon's median deal size is 000000.

  • What is Scott Platshon’s main position?

    Scott Platshon’s primary position is Chief Operating Officer.

  • How many active board seats does Scott Platshon hold?

    Scott Platshon holds 3 board seats including Ajax Therapeutics, Kumquat Biosciences, and Zymeworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »